Fredag 28 November | 00:46:20 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-19 08:00 Bokslutskommuniké 2025
2025-12-18 N/A Extra Bolagsstämma 2025
2025-11-20 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-30 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2025-05-28 - Årsstämma
2025-05-28 - Kvartalsrapport 2025-Q1
2025-02-20 - Bokslutskommuniké 2024
2024-11-21 - Kvartalsrapport 2024-Q3
2024-08-28 - Kvartalsrapport 2024-Q2
2024-05-30 - Kvartalsrapport 2024-Q1
2024-05-16 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2024-05-15 - Årsstämma
2024-02-27 - Extra Bolagsstämma 2024
2024-02-22 - Bokslutskommuniké 2023
2023-11-28 - Kvartalsrapport 2023-Q3
2023-08-30 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2023-05-29 - Årsstämma
2023-05-29 - Kvartalsrapport 2023-Q1
2023-03-13 - Bokslutskommuniké 2022
2023-01-09 - Extra Bolagsstämma 2022
2022-11-28 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-02 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2022-06-01 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-02-23 - Bokslutskommuniké 2021
2021-11-22 - Kvartalsrapport 2021-Q3
2021-08-26 - Kvartalsrapport 2021-Q2
2021-05-18 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2021-05-18 - Kvartalsrapport 2021-Q1
2021-05-17 - Årsstämma
2021-02-25 - Bokslutskommuniké 2020
2020-11-19 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2020-05-14 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-28 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-05-17 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2019-05-16 - Årsstämma
2019-05-16 - Kvartalsrapport 2019-Q1
2019-02-28 - Bokslutskommuniké 2018
2018-11-29 - Kvartalsrapport 2018-Q3
2018-08-30 - Kvartalsrapport 2018-Q2
2018-05-17 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2018-05-16 - Årsstämma
2018-05-16 - Kvartalsrapport 2018-Q1
2018-02-22 - Bokslutskommuniké 2017
2017-11-09 - Kvartalsrapport 2017-Q3
2017-10-06 - Extra Bolagsstämma 2017
2017-08-31 - Kvartalsrapport 2017-Q2
2017-05-12 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2017-05-11 - Årsstämma
2017-05-11 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-10-27 - Kvartalsrapport 2016-Q3
2016-08-24 - Kvartalsrapport 2016-Q2
2016-06-09 - Extra Bolagsstämma 2016
2016-04-22 - Årsstämma
2016-04-22 - Kvartalsrapport 2016-Q1
2016-04-21 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2016-02-10 - Bokslutskommuniké 2015
2015-10-29 - Kvartalsrapport 2015-Q3
2015-08-13 - Kvartalsrapport 2015-Q2
2015-04-22 - X-dag ordinarie utdelning LIDDS 0.00 SEK
2015-04-21 - Årsstämma
2015-04-21 - Kvartalsrapport 2015-Q1
2015-02-20 - Bokslutskommuniké 2014
2014-11-11 - Kvartalsrapport 2014-Q3
2014-08-21 - Kvartalsrapport 2014-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
LIDDS är ett läkemedelsbolag. Bolaget utvecklar läkemedelsprodukter baserade på en patentskyddad och kliniskt testad drug delivery-teknologi. Egenskaperna hos produkterna utgör grunden för LIDDS teknologiplattform för utveckling av injicerbara läkemedelsprodukter. LIDDS är förkortningen för Local Intelligent Drug Delivery System, och bolaget har sitt huvudkontor i Uppsala.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-11-27 18:30:00

LIDDS AB (publ) (“LIDDS” or the “Company”) announces that the Company has entered into an agreement for a reverse takeover of Proport Invest AB (publ) (“Proport”) regarding all shares in Proport (the “Transaction”). The Transaction is, among other things, conditional upon resolutions at an extraordinary general meeting in LIDDS and that shareholders representing at least 90 percent of the shares in Proport participate in and consent to the Transaction. Notice of the extraordinary general meeting will be published by way of a separate press release.

Summary of the Transaction

  • LIDDS has today entered into an agreement with the majority shareholders representing approximately 67.7 percent of the shares in Proport (the “Sellers”) to acquire all shares in Proport for a purchase price of approximately SEK 75 million. The purchase price will be paid in the form of 1,244,868,669 newly issued shares in LIDDS. The Transaction constitutes a reverse takeover.
  • The completion of the Transaction is, among other things, conditional upon (i) an extraordinary general meeting in LIDDS approving the Transaction and resolving on the contribution in kind share issue (directed new share issue against payment in kind) of shares that constitutes the consideration to the shareholders of Proport, (ii) shareholders representing at least 90 percent of the shares in Proport accepting the offer, (iii) LIDDS obtaining conditional approval for continued listing on Nasdaq First North, and (iv) the relevant sellers being granted an exemption from the mandatory bid obligation by the Swedish Securities Council (Sw. Aktiemarknadsnämnden).
  • The consideration to the shareholders of Proport is based on a mutually agreed value of Proport of approximately SEK 75 million, corresponding to SEK 0.54 per share in Proport. For each share in Proport, nine (9) new shares in LIDDS will be received, implying a subscription price of SEK 0.06 per LIDDS share. A total of up to 1,244,868,669 new shares in LIDDS will be issued as consideration.
  • Following the Transaction and the directed share issue, the shareholders of Proport are expected to together hold approximately 90.1 percent of the shares and votes in LIDDS, while the existing shareholders of LIDDS are expected to hold approximately 9.9 percent.
  • The extraordinary general meeting to resolve on the Transaction and the related contribution in kind share issue is planned to be held in January 2026.
  • The Transaction entails a material change in LIDDS’s operations, which means that LIDDS needs to undergo a new listing review with Nasdaq First North. This review includes the preparation of a company description to be approved by Nasdaq. LIDDS expects to submit the company description for approval as soon as possible. Following completion of the Transaction, LIDDS intends to change its name to Proport Invest AB (publ) and to conduct the business currently carried out by Proport.


About Proport
Proport is a Swedish public investment company. Its operations consist of investments, co-ownership and management, with a particular focus on innovation, e-commerce and digital growth companies with high scalability. Proport’s investments are targeted in particular at entrepreneurs with scalable business models and potential within digital growth sectors. Proport’s portfolio consists of both wholly owned and partly owned companies within fast-growing digital sectors and e-commerce. For more information about Proport and its portfolio, visit www.proport.se.

Statement from LIDDS AB

“For a longer period, LIDDS has developed drug candidates based on the Company’s technology platform. As the conditions for continued development in this area have changed, the Board has evaluated alternative strategic directions. Based on this analysis, the Board has assessed that an acquisition of Proport Invest constitutes an appropriate step that can create value for its shareholders.”
– Daniel Lifveredson, Chairman of the Board, LIDDS AB (publ)

Statement from Proport Invest AB

“Proport views the proposed transaction positively. The principal owners have expressed their support and assess that a market listing will enable Proport to implement its investment plan at a faster pace than as an unlisted company. A public environment and a closer connection to the capital market are deemed advantageous for Proport’s continued development.”
– Marko Radojevic, CEO, Proport Invest AB (publ)

Application for continued listing on Nasdaq First North
The Transaction constitutes a material change in LIDDS’s operations and therefore requires the Company to undergo a new listing process and be approved for continued listing by Nasdaq. As part of this process, a company description will be prepared and published. If Nasdaq does not approve the company for continued listing, there is a risk that LIDDS’s shares will be delisted from Nasdaq First North.

Further details on the Transaction
The purchase price for 100 percent of the shares in Proport amounts to approximately SEK 75 million, which will be paid through a contribution in kind share issue of 1,244,868,669 newly issued shares in LIDDS at a subscription price of SEK 0.06 per share. The Sellers, who represent approximately 67.7 percent of the shares in Proport, have undertaken to participate in the Transaction. The Transaction is conditional upon at least 90 percent of the shareholders in Proport participating in and consenting to the Transaction. To the extent fewer than 100 percent of the shares in Proport participate in the Transaction, the purchase price, and thereby the number of consideration shares, will be reduced proportionally.

The completion of the Transaction is further conditional upon the seller or sellers who, following completion of the Transaction, would reach a voting share of at least thirty (30) percent in LIDDS being, where applicable, granted an exemption from the mandatory bid obligation by the Swedish Securities Council (Sw. Aktiemarknadsnämnden).

The Transaction entails a significant change in LIDDS’s ownership structure. The shareholders of Proport participating in the Transaction will hold approximately 90.1 percent of the shares and votes, while existing shareholders’ holdings will be diluted to approximately 9.9 percent. The Board assesses that the subscription price of SEK 0.06 per share, which forms the basis for the consideration, is at market terms as it is the result of arm’s-length negotiations with the Sellers regarding the value of Proport.